Loading...

Home
ETF
PSNL

PSNL

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

PSNL News

Personalis Secures CE-IVD Mark for Global Deployment of MRD Detection Kits

Jun 09 2026Newsfilter

Personalis CEO Sells 100,000 Shares Amid Stock Surge

Jun 04 2026Fool

Personalis CEO Christopher Hall Sells 100,000 Shares Amid Stock Surge

Jun 04 2026NASDAQ.COM

NeXT Personal® MRD Test Shows 100% Sensitivity for CRC Recurrence

Jun 02 2026Newsfilter

SPDR S&P Oil & Gas ETF Underperforms

May 28 2026NASDAQ.COM

Personalis Secures Expanded Medicare Coverage for NeXT Personal Test

May 20 2026seekingalpha

Medicare Expands MRD Testing Coverage for TNBC and HER2+ Cancer Patients

May 20 2026Newsfilter

Healthcare Stocks Rise 0.8% on NYSE Healthcare Index

May 13 2026Yahoo Finance

Personalis Shares Surge After Medicare Expands Coverage for NeXT Personal Test

May 13 2026seekingalpha

Personalis Secures Medicare Coverage for Immunotherapy Monitoring

May 13 2026Newsfilter

Personalis Q1 2026 Earnings Call Insights

May 08 2026seekingalpha

Personalis (PSNL) Q1 2026 Earnings Transcript

May 08 2026NASDAQ.COM

Personalis Showcases NeXT Personal's Role in Colorectal Cancer Treatment

Apr 21 2026Newsfilter

Personalis Showcases NeXT Personal's Application in Colorectal Cancer

Apr 13 2026Newsfilter

ARK Genomic Revolution ETF Underperforms

Mar 27 2026NASDAQ.COM

Personalis Publishes PREDICT-DNA Study Results

Mar 12 2026Newsfilter